Injection Technique Errors Clinicians See Most (and How to Fix Each)

The mistake

Taking the pen or vial directly from the refrigerator and injecting immediately. Compounded semaglutide and tirzepatide are stored cold (36–46°F/2–8°C), and many patients inject within minutes of removing it.

Why it matters

Cold medication is more viscous, which increases resistance during injection. This causes two problems: the plunger is harder to depress smoothly (leading to jerky, uneven injection), and the subcutaneous depot forms differently, potentially affecting absorption kinetics. Cold injections also sting significantly more, which creates an aversion loop — patients who dread the pain tend to rush through future injections, compounding other technique errors.

The fix

Remove the medication from the refrigerator 15–30 minutes before injection. Set it on the counter in its packaging (out of direct sunlight). Room-temperature medication flows more smoothly, reduces injection pain by approximately 50% based on patient reports, and forms a more consistent subcutaneous depot. Do not microwave, hold under hot water, or otherwise heat the medication — gentle equilibration to room temperature is the only safe method. Most compounded GLP-1s are stable at room temperature for 28–30 days once punctured, per standard compounding guidelines, but verify with your specific pharmacy.

The mistake

Injecting at an angle other than 90 degrees to the skin, or using the wrong approach for the patient's body composition. Clinicians see both extremes: patients who inject nearly parallel to the skin (intradermally) and patients who drive the needle deep into muscle tissue.

Why it matters

GLP-1 receptor agonists are designed for subcutaneous delivery — the layer of fat between the skin and the muscle. Too shallow (intradermal) means the medication pools just under the surface, causing larger injection-site reactions, potential leakback, and inconsistent absorption. Too deep (intramuscular) means faster absorption than intended, which can amplify side effects — especially nausea — and alter the medication's pharmacokinetic profile.

The fix

For most patients, a 90-degree angle with the skin pinched into a fold works correctly with standard 30–31 gauge, 5/16" (8mm) subcutaneous needles. Pinch the skin firmly enough to lift the fat layer away from the muscle beneath it. If you're very lean (low subcutaneous fat), a 45-degree angle with a pinch may be more appropriate to avoid reaching muscle — discuss with your prescriber. If you're using a compounded vial-and-syringe setup, the needle length matters: an insulin syringe with a 1/2" needle at 90 degrees without a pinch is too deep for most abdominal sites.

The mistake

Injecting in the same spot or the same small area every week. This is the most common error by frequency. Many patients find a spot that "works" — usually one particular area of the abdomen — and return to it every time.

Why it matters

Repeated injections in the same tissue area cause lipohypertrophy — a buildup of fatty tissue at the injection site. Lipohypertrophic tissue has altered blood supply, which means medication absorption from that site becomes erratic and unpredictable. You may absorb 70% one week and 40% the next from the same dose. This is a well-documented phenomenon in insulin therapy and applies equally to GLP-1 depot injections. Lipohypertrophy can also cause visible lumps under the skin.

The fix

Use a systematic rotation pattern across three approved injection areas: the abdomen (at least 2 inches from the navel), the front of the thigh (middle third), and the back of the upper arm (if you have enough tissue and can reach it or have assistance). Within each area, offset each injection by at least 1 inch from the previous site. A simple system: right abdomen → left abdomen → right thigh → left thigh, shifting position within each area. Some patients track their rotation on a simple body-map diagram or in their medication log.

The mistake

Pulling the needle out immediately after depressing the plunger. Patients describe wanting to "get it over with" — they inject, pull out, and move on. With autoinjector pens (like branded Ozempic or Wegovy), a click signals completion; with compounded vials and syringes, there's no such signal.

Why it matters

A subcutaneous depot takes a moment to form. If you withdraw the needle immediately, some of the medication can leak back through the needle track — this is called "leakback" or "wet injection." The volume lost is usually small (a few microliters), but over weeks of consistent leakback, the cumulative underdosing can be meaningful. Patients who report seeing a drop of liquid on their skin after every injection are almost certainly experiencing this.

The fix

After fully depressing the plunger, count slowly to ten before withdrawing the needle. Keep the skin pinch held during this count. Ten seconds allows the depot to stabilize in the tissue and the needle track to begin sealing. For autoinjector pens, follow the manufacturer's instructions for hold time (typically 6–10 seconds after the click). If you consistently see a drop of medication on the skin surface, increase your hold time to 15 seconds.

The mistake

Injecting with visible air bubbles in the syringe. This is specific to patients using compounded GLP-1 from multi-dose vials with separate syringes — not relevant for pre-filled autoinjector pens.

Why it matters

A small air bubble in a subcutaneous injection is not dangerous — it won't cause an air embolism (that's an intravenous concern). However, the air bubble displaces medication volume. If your syringe is set to deliver 0.25 mL and a 0.02 mL bubble is occupying part of that space, you're getting approximately 8% less medication than prescribed. Over weeks, this systematic underdosing compounds. Clinicians also report that air bubbles increase injection-site irritation in some patients.

The fix

After drawing medication from the vial, hold the syringe needle-up and tap the barrel gently to float bubbles to the top. Push the plunger slowly to expel the air (and a tiny bit of medication — that's fine). Then adjust the plunger to your prescribed volume. If you're drawing from a cold vial, tiny bubbles form more readily because cold liquid holds more dissolved gas — another reason to let the vial warm to room temperature first. If you're new to vial-and-syringe administration, ask your dispensing pharmacy for a video demonstration or schedule a teaching appointment with your prescriber.

The mistake

Drifting on the injection schedule — injecting on Tuesday one week, Friday the next, then Sunday the week after that. Patients with no set routine tend to remember their injection when they "feel like they need it" rather than on a consistent schedule.

Why it matters

Semaglutide and tirzepatide have half-lives of approximately 7 days. A consistent weekly interval maintains steady-state plasma levels. Irregular dosing creates peaks and valleys — more side effects near the peak, reduced efficacy in the trough, and a harder time distinguishing medication effects from random symptom variation. Consistent dosing also matters for clinical monitoring: your prescriber needs to evaluate your response at steady state, not during a trough from a delayed dose.

The fix

Pick one day and one approximate time and stick to it. Set a recurring weekly alarm. The time of day doesn't matter clinically — morning, afternoon, or evening are all equivalent — but consistency does. If you realize you're more than a day late, see our Missed Dose Decision Tree for exact guidance. If you're within a 1-day window, inject normally and resume your regular schedule.

The mistake

Using whatever syringe/needle combination is cheapest or most available, rather than the gauge and length recommended for subcutaneous GLP-1 administration. Clinicians occasionally see patients using 25-gauge or even 22-gauge needles meant for intramuscular injection because they "couldn't find" the right ones.

Why it matters

Larger-gauge needles (lower number = larger bore) cause more tissue trauma, increase bruising and pain, and can create larger needle tracks that increase leakback. Conversely, needles that are too thin (33+ gauge) can make it difficult to draw viscous compounded solutions from the vial, leading to inaccurate dosing.

The fix

For subcutaneous GLP-1 injections, the standard recommendation is 30 or 31 gauge, 5/16" (8mm) length. If your compounded pharmacy ships syringes, use what they provide. If you're sourcing your own, insulin syringes in 30–31 gauge with 1/2" needles are widely available at any pharmacy and work well for GLP-1 administration. Longer needles (1/2") are fine if you use a skin pinch to avoid intramuscular injection.